ENTITY
Sosei Group

Sosei Group (4565 JP)

33
Analysis
Health CareJapan
Sosei Group Corporation is a holding company which was established through reorganization. The Group companies are biopharmaceutical companies specializing in drug development. Sosei Group enters into license agreements primarily with US, EU, and Japanese companies to market the licensed drugs in Japan and find alternative usage on such drugs.
more
19 Nov 2019 08:33

Japan - Big Shorts on Zozo (3092 JP)

The short notional in the market for the week ended 15 November is US$25.82bn (down by US$480m) with the largest short positions in Itochu Corp...

Logo
487 Views
Share
27 Aug 2019 04:36

🇯🇵 JAPAN • Summer Results & Revision Scores - Large Caps

INTRODUCTION - Following on from our previous Insights covering the Market Composite, Sector and Peer Group Aggregate Results and Results &...

Logo
547 Views
Share
18 Dec 2018 06:43

Japan Pharma - Top Picks

While Gni Group Ltd (2160 JP) is our high risk-high return pick, Mitsubishi Tanabe Pharma (4508 JP)  is a contrarian call in anticipation of value...

bullishSosei Group
26 Sep 2018 13:03

Investment Thesis and Valuation

Key Drivers Royalty from Seebri / Ultibro and QVM149 (expected launch in FY20e) to peak at ¥ 4.86b in FY25e Majority of the potential milestones...

x